Apr 8, 2022

Advocacy group’s advisory board members defect over Biogen Alzheimer’s drug

Posted by in categories: biotech/medical, life extension, neuroscience

The furious debate over Aduhelm has now sparked controversy over the Alliance for Aging Research, which has seen half of its scientific advisory board members resign.

Comments are closed.